Acute left ventricular thrombus occurs in about 3% of all patients with STEMI. Rivaroxaban demonstrated similar efficacy and safety to warfarin for resolution of left ventricular thrombus after ...

The purpose of the current study, known as RIVAWAR, was to compare the effectiveness of rivaroxaban with warfarin in post-heart attack patients who developed a left ventricular thrombus.

Half of renally-cleared rivaroxaban is cleared as unchanged drug and half as inactive metabolites. ‡Potent inhibitors of both CYP3A4 and P-gp include azole antifungals (e.g., ketoconazole ...

The effectiveness of rivaroxaban, a direct oral anticoagulant, in resolving acute left ventricular thrombus in patients with ST-segment elevation myocardial infarction (STEMI) was similar to that ...

Generic drugmaker Aurobindo Pharma has received final approval from the U.S. Food and Drug Administration (U.S. FDA) to manufacture and market Rivaroxaban Tablets USP, 2.5 mg. The approved ...